Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · IEX Real-Time Price · USD
0.788
-0.003 (-0.44%)
Jul 22, 2024, 10:18 AM EDT - Market open
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 22 employees as of September 30, 2023. The number of employees increased by 1 or 4.76% compared to the previous year.
Employees
22
Change (1Y)
1
Growth (1Y)
4.76%
Revenue / Employee
n/a
Profits / Employee
-$1,697,718
Market Cap
141.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Cellectis | 221 |
Zomedica | 144 |
Myomo | 106 |
EUDA Health Holdings | 106 |
Vigil Neuroscience | 69 |
Elevation Oncology | 29 |
PDS Biotechnology | 25 |
CTXR News
- 4 days ago - Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL) - Newsfile Corp
- 5 days ago - Analysts Hunt for Undervalued Biotech Stocks - Newsfile Corp
- 10 days ago - Bloodstream Infections - From Threats to Solutions - Newsfile Corp
- 11 days ago - Biopharma Stocks Transformative Innovation for the Future of Health - Newsfile Corp
- 12 days ago - Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates - PRNewsWire
- 7 weeks ago - Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution - PRNewsWire
- 2 months ago - Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution - PRNewsWire
- 2 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update - PRNewsWire